Quality of Life Assessment: Key Issues in the 1990sIt was over five years ago that the Centre for Medicines Research organized a workshop entitled "Quality of Life: Assessment and Application". This workshop brought together a unique group of participants, some of whom had been involved in studies on quality of life for well over a decade, whilst others were meeting the subject for the first time. This blend of experienced researchers and enthusiastic newcomers was a great stimulus to the discus sions which followed individual presentations as well as that resulting from the study groups. In the ensuing publication, a balance was sought between a consideration of the complex principles underlying the assessment of quality of life and the application of such assessments to specific clinical conditions which necessitated this approach. The organization in 1991 of a second workshop entitled "Quality of Life Assessment: Key Issues in the 1990s" resulted in a further consideration of the quality of life philosophy, concepts and key instruments together with an update on assessing quality of life in a number of major disease areas. Of particular importance was an examination of various viewpoints concerned with ethical questions and their implications, and quality oflife from industry, regulatory and health care purchasers' perspectives. As a result of this second workshop, the editors of the original book referred to above decided to produce a second edition with a number of updates and additional chapters. |
From inside the book
Results 1-5 of 42
Page 20
OPTIMAL LEVEL 19 — 0.8 L clo o Prognosis £ To O.6 -> - Cr -o # wo 5 Weights * * To O.4 go - -E *o T > § 0.2 L O.O to Duration of life (years) -> t1 MINIMAL LEVEL. 2O OUALITY OF LIFE ASSESSMENT: KEY ISSUES IN THE 1990s.
OPTIMAL LEVEL 19 — 0.8 L clo o Prognosis £ To O.6 -> - Cr -o # wo 5 Weights * * To O.4 go - -E *o T > § 0.2 L O.O to Duration of life (years) -> t1 MINIMAL LEVEL. 2O OUALITY OF LIFE ASSESSMENT: KEY ISSUES IN THE 1990s.
Page 34
Levels of well-being are ranked according to subjective preferences that weight time-specific states and function levels. Prognoses are the probabilities of transition among the function levels, as affected by the total environment of ...
Levels of well-being are ranked according to subjective preferences that weight time-specific states and function levels. Prognoses are the probabilities of transition among the function levels, as affected by the total environment of ...
Page 36
A British version of the instrument is available82,103, including weights for the items obtained from a British population104. The Nottingham Health Profile (NHP) is a two-part instrument. Part I contains 38 items that cover 6 domains ...
A British version of the instrument is available82,103, including weights for the items obtained from a British population104. The Nottingham Health Profile (NHP) is a two-part instrument. Part I contains 38 items that cover 6 domains ...
Page 37
Three broad approaches to assigning weights have been used: (1) investigator defined; (2) relative frequencies; and (3) relative preferences. The first, a procedure in which the investigator assigns higher scores to items of a measure ...
Three broad approaches to assigning weights have been used: (1) investigator defined; (2) relative frequencies; and (3) relative preferences. The first, a procedure in which the investigator assigns higher scores to items of a measure ...
Page 38
... attempts to investigate the effects of rater characteristics on preference weights have not found significant effects for such important characteristics as age, sex, income, marital status, or cultural group109.
... attempts to investigate the effects of rater characteristics on preference weights have not found significant effects for such important characteristics as age, sex, income, marital status, or cultural group109.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
11 | |
22 | |
rationale for a single | 65 |
Development testing and use of the Sickness Impact | 95 |
The Nottingham Health Profile | 111 |
an update | 131 |
A health index and output measure | 151 |
life 15D and its applications | 185 |
Measuring the quality of life of patients with Parkinsons | 289 |
Measuring quality of life in hypertension | 321 |
Measuring quality of life in psychiatry | 343 |
R B Joyce | 373 |
Industry perspectives on quality of life | 383 |
A regulatory view | 393 |
The cost effectiveness of pharmaceuticals | 401 |
Requirements for health care purchasers | 413 |
A WHO method for the assessment of healthrelated | 201 |
The OnLine Guide to QualityofLife Assessment | 221 |
Assessing Quality of Life in Major Disease Areas | 235 |
Measuring the quality of life of patients with rheumatoid | 269 |
The importance of quality of life in policy decisions | 427 |
Appendices | 441 |
Other editions - View all
Quality of Life Assessment: Key Issues in the 1990s S R Walker,Rachel M Rosser No preview available - 1992 |
Quality of Life Assessment: Key Issues in the 1990s S.R. Walker,Rachel M. Rosser No preview available - 2012 |
Common terms and phrases
ACE inhibitors activities airways disease analysis angina antihypertensive application areas Assessment of Quality asthma atenolol auranofin behaviour benefits Bergner cancer patients captopril chronic cilazapril clinical trials clinician compared comparison components concepts coronary correlation cost depression dimensions disability distress domains drug dysfunction effects evaluation example factors function scores groups health services health status measures health-related quality hospital hypertension illness impairment important improvement indicators individual instrument interventions interview investigator Kaplan levodopa measure of health measurement of quality medicine methodological methods methyldopa mobility morbidity mortality nifedipine outcome overall pain Parkinson's disease performance physical function population problems propranolol psychiatric psychological psychometric psychosocial QALY questionnaire reliability respiratory response rheumatoid arthritis Rosser self-administered sensitivity Sickness Impact Profile side-effects SIP score specific standard standard gamble statistical surgery symptoms Table tests therapy treatment validity valuation verapamil weights well-being well-years